Eli Lilly is seeking a scientific, technical, and operational leader for the Cardiometabolic Translation & Biomarker Research (CTBR) group’s multi-capability molecular biomarker laboratory at the Lilly Corporate Center in Indianapolis. The laboratory supports drug discovery and development across cardiometabolic areas, including obesity, diabetes, cardiorenal health, women’s health, and aging, using capabilities such as immunoassays, clinical chemistry, and mass spectrometry. The Director serves as a central operational and scientific resource, coordinating day-to-day laboratory execution, helping lead and develop staff, and providing scientific and technical direction across clinical chemistry, mass spectrometry, and multiplex immunoassay platforms. The role manages and scales routine laboratory capabilities as methods transfer from development into operations, and collaborates with adjacent groups, discovery biologists, clinical scientists, and project teams to identify biomarker needs and suitable analytical approaches. The position supports high-quality preclinical and clinical biomarker studies, routine assay expansion, laboratory operations, and staff development. It also advances biomarker strategies relevant to the mechanism of action, efficacy, and safety of Lilly medicines, while promoting reliable, reproducible, and transparent laboratory practices.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree